Zanamivir

Known as: ATC code J05AH01, ATCvet code QJ05AH01, Relenza 
Zanamivir INN /zəˈnæmᵻvɪər/ is a neuraminidase inhibitor used in the treatment and prophylaxis of influenza caused by influenza A and B viruses. It… (More)
Wikipedia

Topic mentions per year

Topic mentions per year

1999-2017
05101519992017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Influenza virus spreads infection by two main surface glycoproteins, namely hemagglutinin (HA) and neuraminidase (NA). NA cleaves… (More)
  • figure 1
  • table 2
  • table 1
  • table 3
  • figure 2
Is this relevant?
2016
2016
As one of the most effective drugs for influenza virus infection, clinical application of zanamivir is restricted with the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Since late March 2013, there has been another global health concern with a sudden wave of flu infections by a novel strain of… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2012
2012
  • International Journal of Pharmaceutical Medicine
  • 2012
 
Is this relevant?
2012
2012
  • International Journal of Pharmaceutical Medicine
  • 2012
 
Is this relevant?
2009
2009
In the context of the recent pandemic threat by the worldwide spread of H5N1 avian influenza, novel insights into the mechanism… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table I
Is this relevant?
2008
2008
 
  • table 1
Is this relevant?
2000
2000
  • HEPAC Health Economics in Prevention and Care
  • 2000
 
Is this relevant?
2000
2000
  • G. H AYDEN, LBERT D. M. E. O STERHAUS, +5 authors K EVIN W IGHTMAN
  • 2000
A BSTRACT Background The sialic acid analogue zanamivir (GG167) is a selective inhibitor of influenza A and B virus… (More)
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
1999
1999
  • Bundesgesundheitsblatt - Gesundheitsforschung…
  • 1999
 
Is this relevant?